·
NM Genomix (Bulgaria) and OncoInv (the Netherlands) have joined forces to make multi cancer early detection available in Bulgaria. OncoSeek® is a patient-friendly product to detect cancer as it is on a blood sample and requires no biopsy or imaging equipment. Starting January 2024 NM Genomix will offer OncoSeek® in Bulgaria as a quicker and less painful means of screening for cancer.